Hidekazu Hirano

16PUBLICATIONS
130CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 08, 2026
Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors.

|Mar 15, 2026
Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer.

Takeru Wakatsuki, Noriko Yamamoto, Naoki Ishizuka

|Feb 06, 2026
Conversion Surgery after Chemotherapy in a Stage IV BRAF V600E-Mutated Laterally Spreading Tumor With Neuroendocrine Component.

Reona Kawamura, Naoya Toyoshima, Masau Sekiguchi

|Jan 28, 2026
Association between bevacizumab administration and delayed wound healing complications before and after central venous port placement in patients with colorectal cancer.

Kohei Takura, Miyuki Sone, Hidekazu Hirano

|Jan 15, 2026
Comprehensive Genomic Profiling of Advanced Anal Adenocarcinoma in Japan.

Nozomu Ogura, Hidekazu Hirano, Kouya Shiraishi

|Nov 18, 2025
Tislelizumab + Chemotherapy in Gastric Cancer: Long-Term RATIONALE-305 Randomized Trial Follow-up.

Marcia Cruz-Correa, Do-Youn Oh, Ken Kato

Pageof 3

Frequent Collaborators

6 joint publications

Ken Kato

4 joint publications

Hirokazu Shoji

3 joint publications

Yukihide Kanemitsu

3 joint publications

Narikazu Boku